Device Trial Radar · NCT07081815
JOCOAT Safety and Tolerability Clinical Trial GLAD-04
Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
24
Planned (sponsor's estimate)
Start
Sep 5, 2025
Primary completion
Nov 2026
Study completion Nov 2027
Sponsor
- Lead sponsor
- ARC Medical Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jul 23, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated device
- No
- Who can join
- All sexes, from 15 years, up to 25 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will assess the safety and efficacy of a new liquid anti-adhesion device, JOCOAT(TM) APN-3003 in patients undergoing knee anterior cruciate ligament reconstruction (ACLR) surgery. This is a single-center, prospective study. Safety and clinical outcomes will be compared with historical controls from enrolled study site patients from NCT03935750 (STABILITY 2) which has evaluated outcomes following ACL rupture in young athletes. A maximum of 24 patients aged 15-25 years undergoing primary anatomic ACLR with quadriceps tendon (QT) graft following a standardized surgical treatment algorithm will be enrolled. All patients will receive JOCOAT(TM) APN-3003 at the end of their surgery.
Conditions
- Surgical Adhesions
Interventions
JOCOAT(TM) APN-3003Device
10 mL of JOCOAT(TM) APN-3003 is applied at the end of surgery
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety of JOCOAT(TM) APN-3003 as measured by number and severity of adverse device effects and serious adverse device effectsTime frame: 3 months after surgery
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Western University
London, Ontario, Canada · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.